Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria

Transfusion

Volumn 48, Issue 7, 2008, Pages 1403-1414

  Herndndez Campo, Pilar M ^a   Almeida, Julia ^a   Acevedo, Maria J ^a   Sanchez, Maria L ^a   Alberca, Ignacio ^a   Vidriales, Belen ^a   Martinez, Elvira ^a   Romero, Juan R ^a   Orfao, Alberto ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD66B ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD14 ANTIGEN; CD157 ANTIGEN; CD24 ANTIGEN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; FC RECEPTOR; LEUKOCYTE ANTIGEN; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN CLASS A PROTEIN; PHOSPHATIDYLINOSITOL GLYCAN-CLASS A PROTEIN;

ADULT; AGED; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE; MALE; MOLECULAR CLONING; MONOCYTE; MUTATIONAL ANALYSIS; NEUTROPHIL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PHENOTYPE; PROTEIN EXPRESSION; BLOOD; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION;

ADP-RIBOSYL CYCLASE; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD24; ANTIGENS, CD46; ANTIGENS, CD55; ANTIGENS, CD59; FEMALE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOPHENOTYPING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; MUTATION; NEUTROPHILS; RECEPTORS, IGG;

EID: 52049102464     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01686.x     Document Type: Article

References (32)

1. Richards SJ, Hillmen P Advances in the laboratory diagnosis of paroxysmal nocturnal hemoglobinuria. Clin Appl Immunol Rev I 2001;1:315-30.
2. Meletis J, Terpos E. Recent insights into the pathophysiology of paroxysmal hemoglobinuria nocturnal. Med Sci Monit 2003;9:RA161-172.
3. Tomita M. Biochemical background of paroxysmal nocturnal hemoglobinuria. Biochim Biophys Acta 1999;1455:269- 86.
4. Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993;73:703-11.
5. Mortazavi Y, Merk B, Mclntosh J, Marsh JC, Schrezenmeier H, Rutherford TR. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): a high incidence of multiple mutations and evidence of a mutational hot spot. Blood 2003;101:2833-41.
6. Nafa K, Mason PJ, Hillmen P, Luzzato L, Bessler M. Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type. Blood 1995;86:4650-5.
7. Yoon JH, Cho HI, Park SS, Chang YH, Kim BK. Mutation analysis of the PIG-A gene in Korean patients with paroxysmal nocturnal haemoglobinuria. J Clin Pathol 2002;55:410-3.
8. Endo M, Ware RE, Vreeke TM, Singh SP, Howard TA, Tomita A, Holguin MH, Parker CJ. Molecular basis of the heterogeneity of expression of glycosylphosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996;87:2546-57.
9. Piedras J, López-Karpovitch X. Flow cytometric analysis of glycosylphosphatidylinositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size. Cytometry 2000;42:234-8.
10. Rosse W. Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine 1997;76:63-93.
11. Hernandez-Campo PM, Almeida J, Sanchez ML, Malvezzi M, Orfao A. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: a frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom 2006;70:71-81.
12. Hernández-Campo PM, Almeida J, Matarraz S, de Santiago M, Sanchez ML, Orfao A. Quantitative analysis of the expression of glycosylphosphatidylinositol-anchored proteins during the maturation of different hematopoietic cell compartments of normal bone marrow. Cytometry B Clin Cytom 2007;72B:34-42.
13. Van der Schoot CE, Huizinga TW, van't Veer-Korthof ET, Wijmans R, von Pinkster J, dem Borne AE. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria: description of a new diagnostic cytofluorometric assay. Blood 1990;76:1853-9.
14. Kwong YL, Lee CP, Chan TK, Chan LC. Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. Am J Clin Pathol 1994;102:30-5.
15. Nishimura J, Murakami Y, Kinoshita T. Paroxysmal nocturnal hemoglobinuria: an acquired disease. Am J Hematol 1999;62:175-82.
16. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:3699-709.
17. Hernández-Campo PM, Martín-Ayuso M, Almeida J, López A, Orfao A. Comparative analysis of different flow cytometry-based immnophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets. Cytometry 2002;50:191-201.
18. Iyer SB, Bishop JE, Abrams B, Maino VC, Ward AJ, Christian TP, Davis KA. QuantiBRITE: a new standard for fluorescence quantitation (White Paper). San Jose (CA): Becton Dickinson Immunocytometry Systems; 1997.
19. Lenkei R, Andersson B. Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Methods 1995;183:267-77.
20. Endo M, Ware RE, Vreede TM, Howard TA, Parker CJ. Identification and characterization of an inherited mutation of PIG-A in a patient with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1996;93:590-3.
21. Hall SE, Rosse W. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996;87:5332-40.
22. Thomason RW, Papiez J, Lee RV, Szczarkowsi W. Identification of unsuspected PNH-type cells in flow cytometric immunophenotypic analysis of peripheral blood and bone marrow. Am J Clin Pathol 2004;122:128-34.
23. Richards SJ, Rawstron AC, Hillmen P Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry 2000;42:223-33.
24. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-color flow cytometry with monoclonal antibodies to DAF and CD59/MACIE. Br J Haematol 1993;85:378-86.
25. Olteanu H, Karandikar NJ, McKenna RW, Xu Y. Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol 2006;126:781-8.
26. Luzzatto L. Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism. Curr Opin Genet Dev 2006;16:317-22.
27. Funaro A, Ortolan E, Ferranti B, Gargiulo L, Notaro R, Luz- zatto L, Malavasi F. CD157 is an important mediator of neutrophil adhesion and migration. Blood 2004;104:4269-78.
28. Richards SJ, Norfolk DR, Swirsky DM, Hillmen P. Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria. Blood 1998;92:1799-806.
29. PMN (CD16) in paroxysmal nocturnal hemoglobinuria. J Clin Invest 1991;87:58-67.
30. Ariel O, Kukulansky T, Raz N, Hollander N. Distinct membrane localization and kinase association of the two isoforms of CD58. Cell Signal 2004;16:667-73.
31. Johnson RJ, Hillmen P. Paroxysmal nocturnal hemoglobinuria: nature's gene therapy? J Clin Pathol: Mol Pathol 2002;55:145-52.
32. Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA. PIG-A mutations in normal hematopoiesis. Blood 2005;105:3848-54.